Jul 08, 2016
6:5
For every 5 shares held, investors received 6. The price per share adjusted from $25.32 to $21.10.
The split itself did not change the total investment value.
Shanxi C&Y Pharmaceutical Group Co., Ltd. Class A (SZSE:300254) operates in the Pharmaceuticals: major industry.
Shanxi C&Y Pharmaceutical Group Co., Ltd. Class A company overviewShanxi C&Y Pharmaceutical Group Co., Ltd. Class A's most recent stock split was on July 8, 2016. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.
Shanxi C&Y Pharmaceutical Group Co., Ltd. Class A (SZSE:300254) has split its stock 2 times: a 6-for-5 split on June 15, 2015 and a 6-for-5 split on July 8, 2016.
Shanxi C&Y Pharmaceutical Group Co., Ltd. Class A has split its stock 2 times. This history records 2 forward splits between June 15, 2015 and July 8, 2016.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Shanxi C&Y Pharmaceutical Group Co., Ltd. Class A's 6-for-5 split on July 8, 2016, every 5 shares became 6 shares.
Shanxi C&Y Pharmaceutical Group Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on July 8, 2016, 10 years ago. Companies announce splits in advance, and any new SZSE:300254 split will appear on this page.
Already premium?